selected publications
-
academic article
- Estrogen receptor-beta is a potential target for triple negative breast cancer treatment.. Oncotarget. 9:33912-33930. 2018
- Expression of Wnt3 activates Wnt/β-catenin pathway and promotes EMT-like phenotype in trastuzumab-resistant HER2-overexpressing breast cancer cells.. Molecular cancer research : MCR. 10:1597-606. 2012